Impaired Interoception in a Preclinical Model of Functional Dyspepsia by John H. Winston et al.
ORIGINAL ARTICLE
Impaired Interoception in a Preclinical Model of Functional
Dyspepsia
John H. Winston1 • Jose E. Aguirre1 • Xuan-Zheng Shi1 • Sushil K. Sarna1,2
Received: 7 October 2016 / Accepted: 1 February 2017
 The Author(s) 2017. This article is an open access publication
Abstract
Introduction The etiologies of functional dyspepsia
symptoms, including postprandial distress syndrome,
remain unknown. We tested the hypothesis that neonatal
colon inflammation induces postprandial distress syn-
drome-like symptoms in adult life that associate with
increased activation of vagal afferent pathways and fore-
brain limbic regions.
Results These rats showed a significant decrease in nutri-
ent meal consumption to satiety after an overnight fast,
decrease in gastric emptying, decrease in total distance
traveled, and decrease in percent distance traveled in
midfield versus control rats in open field test, indicating
postprandial anxiety- and depression-like behaviors. Adult
naı¨ve rats treated with oral iodoacetamide to induce H.
pylori-like mild gastritis demonstrated similar postprandial
effects as the above rats.
Conclusions We concluded that neonatal colon inflam-
mation is a risk factor for the development of postprandial
distress syndrome-like symptoms. While mild gastritis can
induce symptoms similar to those of neonatal colon
inflammation, gastritis in these rats does not worsen the
symptoms.
Keywords Functional dyspepsia  Anxiety  Visceral
hypersensitivity  Gastric emptying  Visceral pain
Introduction
Functional dyspepsia (FD) is characterized by a cluster of
diverse symptoms, including epigastric pain, burning, dis-
comfort, early satiety, impaired gastric emptying, nausea,
vomiting, anxiety, and depression [1, 2]. These symptoms
are heterogeneous among cohorts and may occur inter-
mittently or continuously in individual patients. Rome III
criteria classified these symptoms into two categories:
postprandial distress syndrome (PDS) and epigastric pain
syndrome (EPS). PDS constitutes bothersome postprandial
fullness and early satiety, whereas EPS constitutes epi-
gastric pain and burning. The temporal variation and
diversity of symptoms in individual patients and their
heterogeneity among cohorts suggest potential biological
abnormalities of the neuromuscular apparatus in the gastric
wall, afferent sensory neurons, autonomic neurons, spinal
cord transmission to the CNS and central processing of the
signals reaching the CNS. The temporal variations suggest
sensitivity of the biological abnormalities to environmental
and psychological factors. The underlying cellular mech-
anisms of these abnormalities remain unknown primarily
because of lack of availability of live tissues from human
internal organs as well as limitations of the use of
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interventional approaches in humans because of ethical and
safety considerations.
On the other hand, epidemiological studies have iden-
tified adverse early-life experiences as risk factors for the
development of FD symptoms [3, 4]. In addition, experi-
mental clinical studies have identified hypersensitivity to
gastric balloon distension, which contributes to epigastric
pain in FD patients [5–8]. Taking cues from the epidemi-
ological findings, animal studies in rodents demonstrated
that neonatal colon or gastric inflammation is one of the
adverse early-life experiences that upregulate sensitivity to
gastric balloon distension [9, 10]. It was also demonstrated
that the upregulation of nerve growth factor (NGF) in the
gastric fundus and brain-derived neurotrophic factor
(BDNF) in the thoracic dorsal root ganglia and LS spinal
cord as well as downregulation of Kv1.1 channels in the
dorsal root ganglia underlies hypersensitivity to gastric
distension [9].
Together, the above clinical and basic science findings
support a potential role of splanchnic pathway sensitization
in generating the symptom of epigastric pain. Less than
half of FD patients demonstrate hypersensitivity to gastric
distension that correlates with postprandial epigastric pain
[6]. By contrast, the non-painful symptoms of PDS, such as
early satiety, discomfort, and altered gastric emptying,
occur following a meal [11, 12] and they may not neces-
sarily utilize the splanchnic neuronal pathway. In this
study, we investigated whether the preclinical model of
neonatal colon inflammation also mimics the non-painful
symptoms of FD patients, such as early satiety, discomfort,
delayed gastric empting, and anxiety- and depression-like
behaviors; if so which afferent neuronal pathways underlie
these symptoms.
A subset of FD patients is diagnosed with H. pylori
infection that causes mild chronic gastritis [13–15]. The
resulting innate and adaptive immune response impairs the
gastric epithelium and causes peptic ulcer disease, gastric
adenocarcinoma, and mucosa-associated lymphoid tissue
lymphoma. Therefore, it was postulated that H. pylori
infection may also target the other types of effector cells in
the gastric wall, such as the afferent nerve terminals,
smooth muscle cells, and enteric neurons to induce or
contribute to FD-like symptoms. However, H. pylori
eradication in FD patients produces little or modest
improvement in symptoms in FD patients [16–18].
Accordingly, a potential role of H. pylori infection in the
pathology of FD has remained uncertain. We will induce
mild gastritis with oral iodoacetamide treatment in adult
rats subjected previously to neonatal colon inflammation to
investigate whether it contributes to the PDS symptoms,
such as early satiety, discomfort, delayed gastric emptying,
and anxiety-like behavior.
Overall, we will test the hypothesis that neonatal colon
inflammation sensitizes the interoception circuits so that
ingestion of a meal in adult life over activates the
hypothalamus and limbic regions that associate with early
satiety, discomfort, anxiety-like behavior, and delayed
gastric emptying. We will investigate also whether mild
gastritis induced by oral iodoacetamide induces similar
symptoms in naı¨ve adult rats as neonatal colon inflamma-




Male Sprague–Dawley rats, each weighing 300–350 g, and
10-day-old male pups were used in these studies. The
IACUC at UTMB approved all procedures performed on
these animals.
Experimental Groups
The rats were randomly assigned to one of four treatment
groups: intracolonic administration of saline in 10-day-old
rat pups, which received regular drinking water as adults
(control rats); neonatal colon inflammation (NCI) induced
by intracolonic administration of 0.2 ml of 130 mg/kg
trinitrobenzene sulfonic (TNBS) acid in 10% ethanol
through a catheter inserted 2 cm into the colon (NCI rats);
adult gastritis (AG) induced by seven-day treatment with
0.1% iodoacetamide in drinking water (AG rats), and
10-day-old neonatal rats treated with 130 mg/kg TNBS
followed by treatment with 0.1% iodoacetamide as above
at 6–8 weeks of age (NCI ? AG rats). Experiments were
performed 7 days after the end of the above adult
treatments.
Liquid Nutrient Meal Test
We investigated the effects of neonatal colon inflammation
and adult gastritis on consumption volumes of liquid
nutrient meals (Ensure, homemade vanilla; Abbott
Nutrition, Columbus, OH) consumed to satiety within
30 min in overnight fasted un-entrained rats. Enough
Ensure was provided to enable each rat to reach satiety.
The rats were pre-exposed to the test diet to reduce neo-
phobia and acclimatize them to wire bottom cages for 48 h
before subjecting them to an overnight fast. Tissues were
collected 60 min after end of the meal. Gastric emptying
rates and magnitude of neuronal activation revealed by
c-Fos IR in the dorsal vagal complex (DVC), central
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nucleus of the amygdala (CeA), and the paraventricular
nucleus (PVN) were measured [19]. Stomachs were
removed and contents weighed. Gastric emptying rate was
expressed as: [volume of Ensure consumed (ml)-volume
of stomach contents (ml)]/Ensure consumed (ml) 9 100.
A total of 47 adult rats were used, n = 11–12 in each
group.
Full thickness duodenum and gastric fundus tissues were
frozen for measurement of inflammatory cytokines. The
numbers of c-Fos IR nuclei were counted in thoracic spinal
cord segments T7-T12, DVC, CeA, and PVN by laboratory
staff blinded to experimental groups. Three to five rats per
group were examined (Table 1).
c-Fos and CGRP Immunohistochemistry
The rats were anaesthetized by an intraperitoneal injection
of pentobarbital (100 mg/kg body weight) and were per-
fused transcardially with 50 ml PBS ? 5U heparin/ml and
then with 150 ml ice cold 4% paraformaldehyde in PBS.
The brains were left overnight at 4 C in the fixative, then
kept in 20% sucrose in 19 PBS at 4 C for 24 h, and then
rapidly frozen on dry ice and stored at -80 C. The frozen
brains were cut into 40-lm coronal slices using a sliding
microtome (Leica SM200R, Buffalo Grove, IL). The brain
sections obtained from the free-floating sections were
rinsed three times in PBS, incubated for 2 h at room tem-
perature in a blocking solution of PBS containing 5%
normal goat serum, 0.3% Triton X-100 (Sigma-Aldrich, St.
Louis, MO, USA), and were incubated with c-Fos Ab-5
1/20,000 in the blocking solution for 72 h at 4 C with
gentle agitation (EMD Chemicals, San Diego, CA). The
sections were then rinsed with PBS ? 0.3% Triton X-100,
incubated with biotinylated secondary antibody against
rabbit [1:600, Vectastin ABC kit (Vector Laboratories,
Burlingame, CA) in the blocking solution, rinsed in PBS,
incubated in avidin–peroxidase complex (ABC, reagent;
Vector Laboratories), and rinsed in PBS. Neurons
immunoreactive for c-Fos were visualized as brown color
after a 10-min incubation in 3,30-diaminobenzidine (SK-
4100; Vector Laboratories). The brain sections were then
rinsed three times in water, mounted on SuperFrost slides
(Fisher Scientific, Pittsburgh, PA, USA), dried, dehydrated
through graded alcohols, washed in xylenes, and cover-
slipped with Organo/Limonene Mount, Sigma]. Serial
sections were probed with Rabbit anti-CGRP, 1/4000,
Calbiochem PC205L, and same secondary antibody pro-
cedures as used for c-Fos staining.
c-Fos Quantitation
Cells were considered c-Fos positive if their nuclei con-
tained detectable brown immunolabeling, regardless of
labeling intensity. The cells were considered c-Fos nega-
tive, if they displayed no visible nuclei or the nuclei were
lacking c-Fos immunolabeling. DVC c-Fos was counted
bilaterally in tissue sections through the rostro-caudal
extent of the area postrema. In each rat, four tissue sections
through the PVN (spaced by 80 lm) that were obtained
from bregma -1 to -2 mm were selected for analysis.
CGRP fiber immunolabeling was used to distinguish the
boundaries of the CeA in sections between bregma -2.3
and -3 mm. c-Fos-positive profiles were counted in 4–6
sections/rat. Regional cell count data for each rat are
expressed as the number of cells counted in each region
unilaterally divided by the number of analyzed tissue sec-
tions through the region (Table 1).
Evaluation of Gastric Inflammation
Gastric tissues were evaluated for inflammation by mea-
suring expression of inflammatory cytokines by quantita-
tive RT-PCR. RNA was isolated using Qiagen RNeasy kit
(Qiagen, Valencia, CA). RT was performed using super
script III kit (Invitrogen, Carlsbad, CA) followed by SYBR
green PCR (Life technologies, Grand Island, NY). PCR
was performed on a Step One Plus (Applied Biosystems
now Thermo Fisher), and fold change relative to control
was calculated with the DDCt method with 18S as the





Table 1 Average numbers of
c-Fos IR nuclei/section
Region ANOVA Ctr. (n = 5) NCI (n = 4) AG (n = 3) NCI ? AG (n = 3)
DVC NCI: F = 11.3, p = 0.006
AG: F = 45.9, p\ 0.001
43 ± 9 62 ± 6* 106 ± 10*@ 152 ± 24*@#
CeA NCI: F = 20.3, p\ 0.001
AG: F = 23.3, p\ 0.001
45 ± 6 83 ± 12* 85 ± 14* 112 ± 12*@
PVN NCI: F = 30.7, p\ 0.001
AG: F = 21.8, p\ 0.001
36 ± 7 96 ± 19* 108 ± 8* 180 ± 19*@#









We used open field test (OFT) to measure the effects of Ad
lib nutrient meal consumption after an overnight fast on
open field activity in Ctr., NCI, and NCI ? AG rats. The
rats were placed in an open field consisting of a
60 9 60 cm box with 30-cm-high walls around. The floor
was divided into a center (20 9 20 cm) and peripheral
areas. The rats were placed individually in the center
always facing the same direction, and they were video-
recorded for 10 min. The recordings were evaluated in a
blinded fashion. The locomotor activity was measured by
the total distance traveled. For anxiety, distance traveled in
the center area of the field expressed as a percentage of the
total distance traveled was measured. Separate groups of
naı¨ve adult rats received either 0.2 ml of 0.15 M LiCl or
0.9% saline (control) 30 min prior to testing.
Statistics
Statistical analyses were performed using Sigmaplot 12.0.
The treatment group data are expressed as mean ± SE.
Meal consumption, gastric emptying, and c-Fos data were
analyzed by two-way ANOVA with Tukey post hoc test.
Otherwise, t-test was used where appropriate. p\ 0.05 was
considered significant.
Results
Early Satiety, Delayed Gastric Emptying,
and Discomfort in NCI, AG, and NCI 1 AG Rats
The volume of Ensure consumed to satiety after an over-
night fast was significantly less in NCI than in control rats
(Fig. 1a; 14.6 ± 1 ml vs. 20.6 ± 1 ml, p\ 0.001,
F1,46 = 14.0, p\ 0.001). The percent gastric emptying
was significantly reduced in NCI rats versus control rats
(Fig. 1b; 20.6 ± 3% vs. 34.6 ± 2%, p\ 0.001,
F1,51 = 8.0, p = 0.007). The induction of adult gastritis by
iodoacetamide in naı¨ve rats decreased Ensure consumption
to satiety by the same degree as that in NCI rats (Fig. 1a).
However, the reduction in gastric emptying by adult gas-
tritis in naı¨ve rats was significantly greater than in NCI rats
(p = 0.001); AG in NCI rats did not decrease gastric
emptying greater than that in AG rats (Fig. 1b).
Open field test results following the consumption of
Ensure meal to satiety after an overnight fast indicated
discomfort/anxiety/fear in NCI rats. The NCI and
NCI ? AG rats traveled significantly shorter total dis-
tances than the control rats (Fig. 2a; p = 0.038 and
p = 0.004, respectively, F2,54 = 3.26, p = 0.049 and
F1,54 = 7.68, p = 0.008, respectively). In addition, the
NCI and NCI ? AG rats traveled significantly less percent
distances in the midfield compared to that of the control
rats (Fig. 2b; p = 0.043 and p = 0.005, respectively;
F2,54 = 3.26, p = 0.049 and F1,54 = 7.92, p = 0.007,
respectively). By contrast, the total distance traveled and
the percent distance traveled midfield by the NCI or
NCI ? AG rats fed Ad lib overnight were not significantly
different from those by the control rats (Fig. 2c, d), sug-
gesting that the behavioral changes in NCI and NCI ? AG
Fig. 1 Nutrient meal test results. a The volumes of Ensure consumed
to satiety after an overnight fast by NCI, AG, and NCI ? AG rats
were significantly less than those consumed by control rats (two-way
ANOVA: neonatal treatment, F1.,46 = 14.0, p\ 0.001, adult gastritis,
F1.,46 = 6.75, p\ 0.013; Ctr. vs. NCI, p\ 0.001; Ctr. vs. AG,
p\ .001; Ctr. vs. NCI ? AG, p\ 0.001). b Graphs showing the
percent of Ensure emptied from the stomach at 1.5 h after the start of
meal consumption (two-way ANOVA, F1,51 = 8.0, p = 0.007 for
NCI–AG interaction; Ctr. vs. NCI, p\ 0.001; NCI vs. NCI ? IAG,
p\ 0.001). *p\ 0.01 versus Ctr.; #p\ 0.01 versus NCI, n = 12
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rats were in response to meal ingestion after an overnight
fast.
c-Fos Activity in Brain Regions
We investigated whether the consumption of Ensure meal
to satiety activated c-Fos IR neurons in the DVC, CeA, and
PVN of control, NCI, AG, and NCI ? AG rats. The c-Fos
reactive neurons in these regions were undetectable after an
overnight fast in each group of rats (data not shown). The
average numbers of c-Fos IR nuclei/section were signifi-
cantly greater in NCI, AG, and NI ? AG rats compared to
controls in DVC, CeA, and PVN (Table 1; Figs. 3a–c, 4).
The c-Fos IR in AG rats was significantly greater than that
in NCI rats only in the DVC. The activation of c-Fos IR
neurons in NCI ? AG rats was greater than in Ctr. and
NCI rats in all three brain regions. However, activation of
c-Fos IR in NCI ? AG rats was greater than that in AG
rats only in the DVC and PVN. We noted that regardless of
the different average volumes of Ensure consumed by the
four groups of rats in c-Fos studies, the average volumes of
liquid retained in the stomach were not significantly
different among the different groups at euthanasia, pri-
marily because of concurrent decreases in meal consump-
tion and rate of gastric emptying. Negligible c-Fos IR was
detected in spinal cord segments T9–T12 (Fig. 3d).
Interoceptive Neural Circuit Activation and Early
Satiety and Discomfort-/Fear-/Anxiety-Like
Behaviors
Lithium chloride (LiCl) activates interoceptive neural cir-
cuits in the brain, including DVC, CeA, and PVN [20]. We
investigated whether LiCl-induced activation of intero-
ceptive neural circuits was associated with early satiety and
discomfort-/fear-/anxiety-like behaviors in naı¨ve adult rats.
LiCl was administered to naı¨ve adult rats 30 min before
nutrient meal consumption and open field test. LiCl treat-
ment significantly decreased Ensure meal consumption
(Fig. 5a, p\ 0.02, t-test) and the total distance traveled
(Fig. 5b, p\ 0.001, t-test) as well as the percent distance
traveled in midfield (Fig. 5c, p\ 0.001, t-test) vs. saline-
treated control rats.
Fig. 2 Open field test results.
a Bar graphs showing mean
total distances traveled in the
open field by Ctr., NCI, and
NCI ? AG rats following
Ensure meal consumption.
b Bar graphs showing the mean
percent distance traveled in the
midfield of the open field by
Ctr., NCI, and NCI ? AG rats
following nutrient meal
consumption; p = 0.043 and
p = 0.005, respectively;
F2,54 = 3.26, p = 0.049 and
F1,54 = 7.92, p = 0.007,
respectively). c Bar graphs
showing mean total distances
traveled Ctr., NCI, and
NCI ? AG rats fed Ad lib.
d Bar graphs showing the
percent distance traveled in the
middle field by Ctr., NCI, and
NCI ? AG rats fed Ad lib
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Gastric Fundus and Duodenal Inflammation in Ctr.,
NCI, AG and NCI 1 AG Rats
We investigated whether the upregulation of some of the key
classical proinflammatory cytokines were associated with
gastric emptying, and discomfort and anxiety-like behavior.
The mRNA levels of IL-1b, TNF-a, IL-10, and IL-12 were
not significantly different between the gastric fundi of the
NCI and NCI ? AG versus the control rats (Fig. 6a–c).
However, INF-c and IL-6 mRNAs were significantly
increased in the gastric fundus of the NCI versus the control
rats (Fig. 6d). In NCI ? AG rats, only IL-6 was upregulated
versus the control rats (Fig. 6e). In the duodenum, NCI or
NCI ? AG caused no significant change in the expression of
cytokines mRNAs we investigated, except that NCI ? AG




brain regions: a dorsal vagal
complex (DVC), b central
nucleus of the amygdala (CeA),
c paraventricular nucleus of the
hypothalamus (PVN) and from
the thoracic spinal cord: d T9–
T12
Fig. 4 Bar graphs depicting the numbers of c-Fos IR neurons in
a DVC (neonatal treatment F1,15 = 11.3, p = 0.006; adult gastritis
F1,15 = 46, p\ 0.001), b CeA (neonatal treatment F1,15 = 20.3,
p\ 0.001; adult gastritis F1,15 = 23.3, p\ 0.001), and c PVN
(neonatal treatment F1,15 = 30.7, p\ 0.001; adult gastritis
F1,15 = 21.8, p\ 0.001). *p\ 0.05 versus Ctr.;
@p\ 0.05 versus




Previous preclinical studies [9, 10, 21] support epidemio-
logical findings that adverse early-life experiences are risk
factors for the development of functional dyspepsia [3, 4].
The preclinical studies demonstrated that neonatal colon or
gastric inflammation/irritation enhances sensitivity to gas-
tric balloon distention, and it induces anxiety- and
depression-like behaviors in response to psychological
stress in later life [9, 10, 21]. However, the PDS symptoms
in FD patients occur following the ingestion of a meal that
only modestly distends the gastric wall as compared with
balloon distension to induce the sensation of epigastric pain
[8, 22]. Our findings advance the field by demonstrating
that neonatal colon inflammation induces the symptoms of
postprandial distress syndrome, including early satiety,
reduced meal consumption, delayed gastric emptying, and
anxiety-like and depression-like behaviors in response to
Fig. 5 Effects of LiCl treatment on meal consumption and open field
activity. a Bar graphs showing mean volumes of ensure consumed by
naı¨ve adult control rats treated i.p. with 0.15 M NaCl or 0.15 M LiCl
(n = 6, *p\ 0.02). b Bar graph showing mean total distances
traveled in the open field by control rats treated i.p. with 0.15 M NaCl
or 0.15 M LiCl (n = 6, *p\ 0.001) following nutrient meal
consumption. c Bar graph showing the mean percent distance traveled
in the middle of the open field by control rats treated i.p. with 0.15 M
NaCl or 0.15 M LiCl (n = 6, *p\ 0.001) following nutrient meal
consumption
Fig. 6 Bar graphs showing cytokine mRNA levels normalized to 18S
RNA in the fundus of control, NCI, AG, and NCI ? AG rats, n = 6.
a IL-1b. (F = 1.98, p = 0.15). b TNF-a (F = 0.86, p = 0.48). c IL-
10 (F = 1.9, p = 0.17). d IL-12 (F = 1.2, p = 0.354). e INF-c
(F = 4.23, p = 0.019). f IL-6 (F = 12.8, p\ 0.001)
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the ingestion of a nutrient meal to satiety after an overnight
fast in later life.
Experimental clinical studies showed that ingestion of a
large nutrient meal initially relaxes the proximal stomach
followed by a modest increase in wall tension that gener-
ates intra-gastric pressures of about 10 mm Hg [5, 8]. The
suppression of this wall tension by sumatriptan or clonidine
relieved some FD symptoms [23]. Our findings agree with
the clinical findings. We noted that the postprandial
affective disorders were present in rats subjected previ-
ously to neonatal colon inflammation only after the con-
sumption of a nutrient meal to satiety after an overnight
fast; they were absent when these rats were fed Ad lib
overnight. Together, the clinical and preclinical findings
suggest that consumption of small meals at a time may
suppress some of the aversive postprandial symptoms.
Our findings show that mild gastritis induced by
iodoacetamide decreases nutrient meal consumption, rate
of gastric emptying; these effects are similar to those in
adult rats subjected previously to neonatal colon inflam-
mation, except that decrease in gastric emptying rate was
greater in AG than in NCI rats. The notable finding was
that the induction of gastritis in NCI rats did not signifi-
cantly enhance the above adverse effects of NCI, which
suggests that each insult may induce nearly maximal
adverse effects and their individual contributions to the
symptoms are not additive. The eradication of H. pylori
infection in a wide majority of FD patients with this
infection makes little or minimal improvement in FD
symptoms [16, 24, 25]. Our findings may explain the lack
of symptom improvements at least in those FD patients
with childhood infections as their underlying etiology. The
modest, but significant, improvement in symptoms in about
10% of the FD patients might be because these patients had
a greater severity of H. pylori infection, which was not
recorded in those studies.
The open field test measures general locomotor activity
and willingness to explore; both relate to anxiety levels
[26], spontaneous discomfort or pain-like behavior [27].
We found that the total distance traveled and the percent
distance traveled in the midfield were significantly reduced
in NCI rats following a nutrient meal ingestion to satiety
versus those in control rats, suggesting that exposure to
robust neonatal colon inflammation induces postprandial
anxiety-like and aversive behaviors in later life. Another
publication reported that psychological stress induces
anxiety- and depression-like behaviors in rats when
exposed to neonatal gastric irritation followed psycholog-
ical stress in later life [21].
The patterns of regional brain activation and deactiva-
tion differ between FD patients and healthy controls during
gastric balloon distention [28–30], suggesting that CNS
Fig. 7 Bar graphs showing cytokine mRNA levels normalized to 18S
RNA in the duodenum of control, NI, adult gastritis, and NI ? IA
rats, n = 6. a IL-1b (F = 4.91, p = 0.01). b TNF-a (F = 1.55,
p = 0.233). c IL-10 (F = 0.9, p = 0.42). d IL-12 (F = 1.1,




processing of gastric afferent information is different in FD
patients compared to controls. These findings highlight the
importance of investigating the effects of meal consump-
tion on regional brain activity in patients and in preclinical
models. Ingestion of food activates spinal and vagal
afferents that project, respectively, to the second order
neurons in the spinal cord and the dorsal vagal complex,
which then convey the information to various forebrain and
limbic areas involved in the regulation of visceral functions
and exploratory behavior [31, 32].
The postprandial effects of decrease in meal consump-
tion, delay in gastric emptying, and increase in anxiety-like
and depression-like behaviors appear to be induced by
vagal afferents. The postprandial gastric afferent signals
did not activate spinal cord c-Fos IR neurons. A large
nutrient meal provides both mechanical and chemical
stimulations (e.g., lipids evoke release of CCK that acti-
vates vagal afferents to reduce food intake. By contrast, the
noxious mechanical response is mediated primarily by
spinal afferents [33]. Noxious balloon distention activates
the vagal afferents as well since c-Fos in DVC was
reduced, but not absent, after splanchnicectomy [34].
During the ingestion of a meal, the neuronal and endo-
crine signals from the stomach and the duodenum are
integrated in the homeostatic control regions of the brain-
stem, such as the amygdala and the hypothalamus
[31, 32, 35]. The activation of these regions can affect
eating behavior, exploratory behavior, and anxiety. We
found significantly greater neuronal activation in the DVC,
CeA, and PVN following nutrient meal consumption to
satiety in overnight fasted NCI, AG, and NCI ? AG rats.
These increases in c-Fos may be due to increased afferent
sensitization of the vagal afferents and/or due to local
sensitization of the forebrain (DVC)-limbic circuits by
neonatal colon inflammation and adult gastritis. Adverse
early-life experiences can sensitize gastric afferents [9, 10]
as well as the central nervous system leading to adverse
effects on behavioral indices of anxiety in adult rats [21].
The pattern of c-Fos activation in response to acid
infusion [36] is similar to that we observed for a large
nutrient meal intake in NCI rats, suggesting that meal
ingestion activates circuits that are activated by noxious as
well as physiological gastroduodenal stimuli. A previous
study reported a significant positive correlation between
postmortem weight of gastric contents and the proportion
of DVC catecholaminergic neurons expressing c-Fos in
naive rats, indicating that activation of these cells is
quantitatively related to the magnitude of feeding-induced
gastric distension [19]. In healthy rats, regional brain
activation patterns mapped by c-Fos immunohistochem-
istry after meal consumption showed activation in the
DVC, CeA, and PVN [19, 32]. Our c-Fos data indicated
that adult gastritis or neonatal colon inflammation each
enhances the central postprandial c-Fos activation.
As stated earlier, both NCI and adult gastritis induce
adverse effects on meal consumption, rate of gastric
emptying, and aversive behaviors in open field test of
similar magnitudes, which are not enhanced with a com-
bination of both insults. On the other hand, gastritis in NCI
rats significantly enhanced c-Fos activation in DVC, CeA,
and PVN. These findings suggest that the observed
behavior changes, decrease in meal consumption, and
delay in gastric emptying may occur at a given level of
c-Fos activation; any additional c-Fos activation may not
further deteriorate the adverse effects we examined. These
findings may explain the clinical findings that treatment of
H. pylori infection in FD patients may have marginal
effects on symptoms [16, 24, 37].
LiCl is an established activator of interoceptive circuits
[20]. Our goal in using LiCl was to show that chemical
activation of the interoceptive circuits produces changes in
behavior and food consumption similar to those in rats
subjected to neonatal colon inflammation. We did not
notice diarrhea or any visual peripheral symptom of LiCl in
our experiments. However, we cannot rule out that an
unknown peripheral effect of LiCl may also have con-
tributed to decrease in nutritional food conniption. The
LiCl experiments also validated the open field test as a
measure of postprandial aversive behavior.
Low-grade inflammation as well as increase in mast cell
infiltration has been reported in the duodenal mucosa of FD
patients including patients [38]. Although we did not
investigate the mast cell numbers or mucosal inflammation
in the duodenum in this study, we found no significant
indication of inflammation as revealed by lack of inflam-
matory cytokine upregulation in our experimental groups.
In a previous study, we found that mast cell numbers in the
fundus were not significantly different between the control
and NCI rats [9].
FD is defined by the lack of detectable organic patho-
physiology [39], although there are reports of low-grade
non-specific immune response in the stomach and/or the
duodenum of FD patients [38]. We reported previously that
adult rats subjected to prior neonatal colon inflammation
demonstrate no detectable classic inflammatory cytokine
expression in the gastric fundus, while they demonstrate
significant hypersensitivity to gastric distension [9].
Iodoacetamide treatment in adult rats produces mild
mucosal gastritis that is characterized by a mild increase in
gastric tissue MPO activity [40]. In this study, we found no
significant differences in the four major inflammatory
cytokine mRNA levels between the fundi of the control,
NCI, AG, or NCI ? AG rats. The exception was the higher
levels of IL-6 in the fundus of NCI and NCI ? AG rats and
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of INF-c in the fundus of NCI rats. This upregulation may
be due to stress on the fundus smooth muscle layers
[41, 42]. Unlike IL-6 signaling in macrophages that
requires activation of NF-jB, intramuscular IL-6 expres-
sion is regulated by the Ca2?/NFAT and glycogen/p38
MAPK pathways [43]. We found no significant differences
in expression of the five cytokines in the duodenum among
our four experimental groups although there was a small
but significant decline in IL-1b mRNA in the duodenum of
adult gastritis rats. These findings suggest that the post-
prandial adverse effects on meal consumption, gastric
emptying, and exploratory behaviors induced by central
c-Fos activation may not be affected by mild immune
response in the stomach or the duodenum.
In conclusion, our findings show that exposure to
neonatal colon inflammation is a risk factor not only for the
induction of gastric hypersensitivity to balloon distension
that relates to epigastric pain, but also for the symptoms of
postprandial distress syndrome, such as early satiety,
decrease in food consumption, aversive behavior, and
delayed gastric emptying. The postprandial interoceptive
signals are transmitted to the central limbic systems
through the vagal nerve. These signals may not originate
from any overt mild inflammation in the gastric fundus or
the duodenum. One cannot rule out that additional factors
such as postprandial release of CCK and ghrelin and
alterations in the enteric neuronal and smooth muscle
regulation of gastric contractions may also contribute to
some of the postprandial symptoms. Identification of the
brain-gut axis circuits altered by adverse early-life expe-
riences implicated in symptom generation, and the cellular
and molecular changes responsible for these alterations in
preclinical models will provide a greater understanding of
disease mechanisms and identify targets for therapeutic
intervention. These findings suggest that in the absence of
readily apparent organic pathophysiology in the stomach
and the duodenum, FD may be defined by cellular bio-
logical abnormalities in the central circuits that process
gastric interoceptive information.
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